FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic ...

A new study reveals that inflammation during pregnancy may impair neurodevelopment in infants by reducing CD11c-positive ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...

Subarachnoid hemorrhage (SAH) can lead to damage to the myelin sheath in white matter. Through classification and analysis of relevant research results, the discussion in this paper provides a deeper ...

Consumption of cannabis is on the rise as public opinion trends toward acceptance and its consequent legalization. Specifically, the senior population is one of the demographics increasing their use ...

Researchers uncover a surprising side effect of marathon running—temporary loss of brain myelin—hinting that the brain may burn its own insulation for energy during extreme physical stress.

Augustine Therapeutics has raised €78m ($85m) in funding to support the development of its lead candidate as it enters a ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately ...